These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 33489015)
1. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p. Yu L; Sui B; Fan W; Lei L; Zhou L; Yang L; Diao Y; Zhang Y; Li Z; Liu J; Hao X J Extracell Vesicles; 2021 Jan; 10(3):e12056. PubMed ID: 33489015 [TBL] [Abstract][Full Text] [Related]
2. LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p/runt-related transcription factor 2/splicing factor proline- and glutamine-rich/polypyrimidine tract-binding protein 2 axis. Mo C; Huang B; Zhuang J; Jiang S; Guo S; Mao X Clin Transl Med; 2021 Aug; 11(8):e493. PubMed ID: 34459124 [TBL] [Abstract][Full Text] [Related]
3. miR-92a-1-5p enriched prostate cancer extracellular vesicles regulate osteoclast function via MAPK1 and FoxO1. Yu L; Sui B; Zhang X; Liu J; Hao X; Zheng L J Exp Clin Cancer Res; 2023 May; 42(1):109. PubMed ID: 37131239 [TBL] [Abstract][Full Text] [Related]
4. Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2. Yang JX; Xie P; Li YS; Wen T; Yang XC Cell Signal; 2020 Jun; 70():109504. PubMed ID: 31857240 [TBL] [Abstract][Full Text] [Related]
5. PC-3-Derived Exosomes Inhibit Osteoclast Differentiation by Downregulating miR-214 and Blocking NF- Duan Y; Tan Z; Yang M; Li J; Liu C; Wang C; Zhang F; Jin Y; Wang Y; Zhu L Biomed Res Int; 2019; 2019():8650846. PubMed ID: 31058194 [TBL] [Abstract][Full Text] [Related]
6. Liver cancer cell-secreted exosomes promote bone metastasis of liver cancer by facilitating osteoclast differentiation through the miR-574-5p/BMP2 axis. Li T; Li M; Peng Y; Li X; Chen Y; Zhang J; Zhang Z; Zhang H; Du J Pathol Res Pract; 2023 May; 245():154485. PubMed ID: 37120909 [TBL] [Abstract][Full Text] [Related]
7. Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation. Wang W; Qiao SC; Wu XB; Sun B; Yang JG; Li X; Zhang X; Qian SJ; Gu YX; Lai HC Cell Death Dis; 2021 Jun; 12(7):628. PubMed ID: 34145224 [TBL] [Abstract][Full Text] [Related]
8. Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway. Liu Y; Yang C; Chen S; Liu W; Liang J; He S; Hui J Cancer Gene Ther; 2023 Mar; 30(3):437-449. PubMed ID: 36434177 [TBL] [Abstract][Full Text] [Related]
9. Osteoclast-Derived Exosomal miR-5134-5p Interferes with Alveolar Bone Homeostasis by Targeting the JAK2/STAT3 Axis. Pan L; Zhang C; Zhang H; Ke T; Bian M; Yang Y; Chen L; Tan J Int J Nanomedicine; 2023; 18():3727-3744. PubMed ID: 37441084 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells. Yuan X; Qian N; Ling S; Li Y; Sun W; Li J; Du R; Zhong G; Liu C; Yu G; Cao D; Liu Z; Wang Y; Qi Z; Yao Y; Wang F; Liu J; Hao S; Jin X; Zhao Y; Xue J; Zhao D; Gao X; Liang S; Li Y; Song J; Yu S; Li Y Theranostics; 2021; 11(3):1429-1445. PubMed ID: 33391543 [No Abstract] [Full Text] [Related]
11. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A. Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427 [TBL] [Abstract][Full Text] [Related]
12. Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice. Furesi G; de Jesus Domingues AM; Alexopoulou D; Dahl A; Hackl M; Schmidt JR; Kalkhof S; Kurth T; Taipaleenmäki H; Conrad S; Hofbauer C; Rauner M; Hofbauer LC Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163219 [TBL] [Abstract][Full Text] [Related]
13. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche. Ma Q; Liang M; Wu Y; Dou C; Xu J; Dong S; Luo F J Extracell Vesicles; 2021 Feb; 10(4):e12068. PubMed ID: 33659051 [TBL] [Abstract][Full Text] [Related]
14. Melatonin Inhibits ET-1 Production to Break Crosstalk Between Prostate Cancer and Bone Cells: Implication for Osteoblastic Bone Metastasis Treatment. Lin LW; Lin TH; Swain S; Fang JK; Guo JH; Yang SF; Tang CH J Pineal Res; 2024 Oct; 76(7):e70000. PubMed ID: 39415320 [TBL] [Abstract][Full Text] [Related]
15. Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts. Liu X; Cao M; Palomares M; Wu X; Li A; Yan W; Fong MY; Chan WC; Wang SE Breast Cancer Res; 2018 Oct; 20(1):127. PubMed ID: 30348200 [TBL] [Abstract][Full Text] [Related]
16. Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts. Ni J; Zhang X; Li J; Zheng Z; Zhang J; Zhao W; Liu L Cell Death Dis; 2021 Jul; 12(7):662. PubMed ID: 34215717 [TBL] [Abstract][Full Text] [Related]
17. GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity. Guo S; Gu J; Ma J; Xu R; Wu Q; Meng L; Liu H; Li L; Xu Y Theranostics; 2021; 11(17):8379-8395. PubMed ID: 34373748 [TBL] [Abstract][Full Text] [Related]
18. Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis. Jiang S; Chen H; He K; Wang J Bioengineered; 2022 Feb; 13(2):2004-2016. PubMed ID: 35030978 [TBL] [Abstract][Full Text] [Related]
19. Osteoblasts-derived exosomes regulate osteoclast differentiation through miR-503-3p/Hpse axis. Wang Q; Shen X; Chen Y; Chen J; Li Y Acta Histochem; 2021 Oct; 123(7):151790. PubMed ID: 34592492 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature. Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]